Amir Kalali, MD is a highly experienced professional who currently holds multiple board member and advisory positions in various biopharma, technology, and research companies. Amir is the co-chair and founder of Decentralized Trials & Research Alliance (DTRA), the founder, chief curator, and chairman of CNS Summit, and a member of the supervisory board at atai Life Sciences. With a MD in Medicine from UCL, Amir also serves on the board of directors for Neuroscience Education Institute and Arbor Scientia, and on the executive committees of International Society for CNS Drug Development and ISCTM. Additionally, Amir acts as a strategic advisor for Holmusk and an advisor for Joyance Partners.
This person is not in any teams
This person is not in any offices
Decentralized Trials & Research Alliance (DTRA)
The DTRA will enable collaboration of stakeholders to accelerate the adoption of patient-focused, decentralized clinical trials and research within life sciences and healthcare through education and research.